Drug comparisons
Methysergide vs Ubrogepant
Compare Methysergide (legacy migraine preventive, fibrosis risk) vs Ubrogepant (Ubrelvy, CGRP antagonist for acute migraines). Safety and uses differ greatly.
No comparison dimensions are available for this page.
Clinical context
This comparison arises when evaluating outdated migraine prophylactics against modern acute CGRP treatments for patients with recurrent attacks.
Bottom line
Ubrogepant is preferred for acute migraines due to better safety, while Methysergide is obsolete with high long-term risks.
All medication comparisons